Pattern of admission and outcome at a newly established sickle cell center in Nigeria
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242727Keywords:
Sickle cell, Admission, OutcomeAbstract
Background: Sickle cell disease (SCD) encompasses a group of autosomal recessive haemoglobinopathies whose genetic mutation leads to the replacement of glutamic acid by valine in position 6 of the beta-globin chain. Most of the world’s SCD burden is in Africa, where it is a major contributor to childhood morbidity and mortality. The study is aimed at determining the pattern of admission and outcome of patients seen at the sickle cell center Asaba, over a two-year period January 2022 to December 2023.
Methods: This was a retrospective descriptive study of children with SCD admitted into the sickle cell center of the Asaba specialist hospital. Information obtained included age, gender, diagnosis, month and year of admission, and outcome. Descriptive statistics was used to describe the demographic characteristics and chi-square to assess their association.
Results: A total of 338 children were seen, 34.5% of the patients were less than 5 years of age; males were 52.6% while 61.6% of the admission occurred during the rainy season. Vaso-occlusive crisis (80.6%) was the most common crisis seen; malaria (51.9%) was the prominent diagnosis made. Case fatality rate was 1.7%.
Conclusions: SCD s remains a major source of admission and mortality in our environment. A comprehensive SCD care plan is needed to reduce the adverse consequences associated with this disease.
References
Abd El-Ghany SM, Tabbakh AT, Nur KI, Abdelrahman RY, Etarji SM, Almuzaini BY. Analysis of causes of hospitalization among children with sickle cell disease in a group of private hospitals in Jeddah, Saudi Arabia. J Blood Med. 2021;12:733-40.
Alhumaid AM, Aleidi AS, Alfakhri AS, Alosaimi NK, Ali YZ, Alzahrani MS. Clinical features and outcome of sickle cell anaemia in a ertiary center: A retrospective cohort study. J Appl Hematol. 2018;9:22-8.
Dennis‐Antwi JA, Opoku SA, Osei‐Amoh B. Survey of educational needs of health workers and consumers in Ghana prior to the institution of newborn screening for sickle cell disease in Kumasi. Heal Cour. 1995;5(4):28‐32.
Aliyu ZY, Kato GJ, Taylor JT, Babadoko A, Mamman AI, Gordeuk VR, et al. sickle cell disease an pulmonary hypertension in Africa: A global perspective and review of epidemiology, pathophysiology and management. Am J Haematol. 2008:83(1):63-70
Santer N. Sickle cell symposium. East Afr Med J. 1976;53:47-53.
Federal Ministry of Health Nigeria. National Guideline for the control and management of Sickle cell disease 2014. Available at: http://www.health.gov.ng/doc/SCDGuideline.pdf. Accessed on 25 June 2024.
Centers for Disease Control and Prevention. Global Health Nigeria: Sickle Cell Disease. Available at: http://www.cdc.gov/globalhealth/countries/nigeria/what/scd.htm. Accessed on 25 June 2024.
Sergeant G R. The clinical features of sickle cell disease. Baillieres Clin Haematol. 1993;6(1):93-115
Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Ann Saudi Med. 2011;31(3):289-93.
Saidi H, Smart LR, Kamugisha E, Emmanuela EA, Deogratias S, Robert NP, et al. Complications of sickle cell anaemia in children in northwestern Tanzania. Hematology. 2016;21(4):248-56.
Alkot M, Almaghrabi WA, Najdi NA, Al NN. Prevalence of complications of sickle cell disease at Makkah Al-Mukaramah, Saudi Arabia, 2017. Ann Clin Lab Res. 2018;6:1.
Aloni MN, Kadima BT, Ekulu PM, Aléine NB, René MN, Jean LGE. Acute crises and complications of sickle cell anemia among patients attending a pediatric tertiary unit in Kinshasa, Democratic Republic of Congo. Hematol Rep. 2017;9(2):6952.
Sawe HR, Reynolds TA, Mfinanga JA, Michael SR, Brittany LM, Lee AW, et al. The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania. BMC Hematol. 2018;18:25.
Akar NA, Adekile A. Ten-Year review of hospital admissions among children with sickle cell disease in Kuwait. Med Princ Pract 2008;17:404-8.
Brown BJ, Jacob NE, Lagunju IA, Jarrett OO. Morbidity and mortality pattern of hospitalized children with sickle cell disorder at the university college hospital, Ibadan, Nigeria. Niger J Paed. 2013;40(1):34-9.
Smith-Whitley K. Sickle cell disease. In: Kliegman RM, Blum NJ, Shah SS, St Geme III JW, Tasker RC, Wilson KM (ed). Nelson Textbook of Pediatrics. 21st ed. Inter ed, Elsevier. 2020;2541-51.
Savlov D, Beck CE, DeGroot J, Odame I, Friedman JN. Predictors of bacteraemia among children with sickle cell disease presenting with fever. J Pediatr Hematolol Oncol. 2014;36(5):384-8
West BA, Aitafo JE. Prevalence, Pattern of Disease and Outcome of Children with Sickle Cell Disease Admitted in a Private Health Facility in Southern Nigeria. Asian J. Pediatr. Res. 2023;12(1):17-27.
Abhulimhen B, Isreal-Aina Y, Joel-Utomakili K. Sickle cell anaemia: Morbidity profile and outcome in a paediatric emergency setting in Nigeria. Afr J Med Health Sci. 2015;14(2):79.
Faruk JA, Adebiyi MN, Ahmad HR. Clinico-demographic characteristics, morbidity and mortality patterns of sickle cell disease in a tertiary institution. Sahel Med J. 2022;25(2):52-6.
Ikefuna AN, Emodi IJ. Hospital admission of patients with sickle cell anaemia pattern and outcome in Enugu area of Nigeria. Niger J Clin Pract. 2007;10(1):24-9.
Slovis CM, Talley TD, Pitts RB. No relationship of climatic factors and painful sickle cell anaemia crisis. J Chron Dis. 1986;39:121-6.
Chirico EN, Pialoux V, Lyon D, Lyon CB. The role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB life. 2012;64:72-80.
Edelu BO, Eze BN, Oguonu T, Ndu I. Morbidity and mortality pattern in the children emergency unit of the University of Nigeria Teaching Hospital, Enugu. Orient J Med. 2014;26(3-4):73-5.
Etuk EE, Akpan MU. The pattern of morbidity in children with sickle cell anaemia at the University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria. Inter J Health Sci Res. 2015;5(5):91-7.
